Role of liposome in treatment of overactive bladder and interstitial cystitis
Intravesical (local) therapy of agents has been effective in delaying or preventing recurrence of superficial bladder cancer. This route of drug administration has also shown tremendous promise in the treatment of interstitial cystitis/painful bladder syndrome (IC/PBS) and overactive bladder without...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-03-01
|
Series: | Urological Science |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1879522614001225 |
id |
doaj-2b6a9a17787645f9b75ea2a8330e42aa |
---|---|
record_format |
Article |
spelling |
doaj-2b6a9a17787645f9b75ea2a8330e42aa2020-11-24T22:49:32ZengWolters Kluwer Medknow PublicationsUrological Science1879-52262015-03-012613610.1016/j.urols.2014.12.008Role of liposome in treatment of overactive bladder and interstitial cystitisShih-Ya Hung0David D. Chancellor1Michael B. Chancellor2Yao-Chi Chuang3Division of Urology, Department of Surgery, Yuan's General Hospital, Kaohsiung, TaiwanLipella Pharmaceuticals, Inc., Pittsburgh, PA, USALipella Pharmaceuticals, Inc., Pittsburgh, PA, USADivision of Urology, Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, TaiwanIntravesical (local) therapy of agents has been effective in delaying or preventing recurrence of superficial bladder cancer. This route of drug administration has also shown tremendous promise in the treatment of interstitial cystitis/painful bladder syndrome (IC/PBS) and overactive bladder without systemic side effects. Liposomes are lipid vesicles composed of phospholipid bilayers surrounding an aqueous core. They can incorporate drug molecules, both hydrophilic and hydrophobic, and show greater uptake into cells via endocytosis. Intravesical liposomes have therapeutic effects on IC/PBS patients, mainly because of their ability to form a protective lipid film on the urothelial surface. Recent studies have shown the sustained efficacy and safety of intravesical instillation of botulinum toxin formulated with liposomes (lipo-BoNT) for the treatment of refractory overactive bladder This review considers the current status of intravesical liposomes or liposomal mediated drug delivery for the treatment of IC/PBS and overactive bladder.http://www.sciencedirect.com/science/article/pii/S1879522614001225interstitial cystitisliposomeoveractive bladder |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shih-Ya Hung David D. Chancellor Michael B. Chancellor Yao-Chi Chuang |
spellingShingle |
Shih-Ya Hung David D. Chancellor Michael B. Chancellor Yao-Chi Chuang Role of liposome in treatment of overactive bladder and interstitial cystitis Urological Science interstitial cystitis liposome overactive bladder |
author_facet |
Shih-Ya Hung David D. Chancellor Michael B. Chancellor Yao-Chi Chuang |
author_sort |
Shih-Ya Hung |
title |
Role of liposome in treatment of overactive bladder and interstitial cystitis |
title_short |
Role of liposome in treatment of overactive bladder and interstitial cystitis |
title_full |
Role of liposome in treatment of overactive bladder and interstitial cystitis |
title_fullStr |
Role of liposome in treatment of overactive bladder and interstitial cystitis |
title_full_unstemmed |
Role of liposome in treatment of overactive bladder and interstitial cystitis |
title_sort |
role of liposome in treatment of overactive bladder and interstitial cystitis |
publisher |
Wolters Kluwer Medknow Publications |
series |
Urological Science |
issn |
1879-5226 |
publishDate |
2015-03-01 |
description |
Intravesical (local) therapy of agents has been effective in delaying or preventing recurrence of superficial bladder cancer. This route of drug administration has also shown tremendous promise in the treatment of interstitial cystitis/painful bladder syndrome (IC/PBS) and overactive bladder without systemic side effects. Liposomes are lipid vesicles composed of phospholipid bilayers surrounding an aqueous core. They can incorporate drug molecules, both hydrophilic and hydrophobic, and show greater uptake into cells via endocytosis. Intravesical liposomes have therapeutic effects on IC/PBS patients, mainly because of their ability to form a protective lipid film on the urothelial surface. Recent studies have shown the sustained efficacy and safety of intravesical instillation of botulinum toxin formulated with liposomes (lipo-BoNT) for the treatment of refractory overactive bladder This review considers the current status of intravesical liposomes or liposomal mediated drug delivery for the treatment of IC/PBS and overactive bladder. |
topic |
interstitial cystitis liposome overactive bladder |
url |
http://www.sciencedirect.com/science/article/pii/S1879522614001225 |
work_keys_str_mv |
AT shihyahung roleofliposomeintreatmentofoveractivebladderandinterstitialcystitis AT daviddchancellor roleofliposomeintreatmentofoveractivebladderandinterstitialcystitis AT michaelbchancellor roleofliposomeintreatmentofoveractivebladderandinterstitialcystitis AT yaochichuang roleofliposomeintreatmentofoveractivebladderandinterstitialcystitis |
_version_ |
1725675974362660864 |